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SUMMARY The purpose of this retrospective and hospital-based 
study was to evaluate the epidemiology of nonmelanoma and mela-
noma skin cancer at University Department of Dermatology and Ve-
nereology, Zagreb University Hospital Center and School of Medicine 
during the 2003-2006 period. The study yielded population based 
results on 2911 cases of skin tumors in 2402 patients out of 16938 
biopsies performed at Laboratory of Dermatologic Histopathology, 
University Department of Dermatology and Venereology, Zagreb Uni-
versity Hospital Center nd School of Medicine during the study period. 
All newly diagnosed invasive and in situ skin cancers were recorded 
by use of the histopathology record forms. Basal cell carcinoma was 
most commonly identified in the histopathology material (n=2002), fol-
lowed by squamous cell carcinoma (n=533), melanoma (n=46) and 
cutaneous lymphoma (n=35). Other, less common tumors were noted. 
The number of tumors, and differences in age, sex and localization 
were analyzed. During the study period, there was no increase in the 
total number of cases recorded: 4305, 4202, 4116 and 4315, respec-
tively. Study results showed skin tumors to be mostly diagnosed in 
elderly population (median age, 71 years). There were no significant 
sex differences, with the exception of the adult age group in 2006. 
As expected, skin tumors were mostly found in sun-exposed areas 
with some specific localization of individual tumor types. Study results 
were consistent with recent literature data. 
KEY WORDS: epidemiology, skin tumors, melanoma skin tumors, 
nonmelanoma skin tumors
INTRODUCTION
The Croatian National Cancer Registry covers 
all estimated melanomas but not all nonmelano-
ma skin cancers recorded in Croatia. Cutaneous 
melanoma and nonmelanoma cancers represent 
more than one-third of all malignant tumors and 
therefore present great burden for health services 
worldwide. Skin cancer is therefore an important 
public health issue in Caucasians and a major bur-
den for dermatologists, general practitioners and 
surgeons. There is a significant increase in the 
incidence of these skin tumors worldwide. Many 
authors describe the rising incidence of nonmela-
noma skin cancer (NMSC) and melanoma (MM) 
(1-33).
Epidemiology, clinical appearance, diagnosis 
and therapy are the most important aspects to 
identify and understand the nature of cutaneous 
tumors. Historically, ascertainment of NMSC world-
wide has been shown to be incomplete in several 
studies; however, recent evidence suggests some 
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improvement of the situation since these records 
are now mainly collected via electronic systems 
(9). While clinical aspects and therapy are well 
known, there are little data available on the epide-
miology of NMSC in Croatia, since data on these 
tumors have not yet been systematically collected. 
Mandatory notification is required only for patients 
admitted to hospital.
In Croatia, only data on patients hospitalized at 
University Departments of Dermatology and Ve-
nereology in Zagreb, Split and Rijeka have been 
systematically collected using oncotypes and then 
analyzed. Dermatovenereologists have studied 
cancer registration only in some centers in Croa-
tia, pointing out that the importance of NMSC is 
underestimated, since most of the patients with 
NMSC are not admitted to hospital but are treated 
at outpatient services without registration in the 
Croatian National Cancer Registry in Zagreb. 
Therefore, the total number of cutaneous cancers 
and their incidence are obviously underestimated. 
Although an increase has recently been observed 
in the number of cutaneous cancers, to date no 
study has been conducted to assess this trend.
Basal cell carcinoma (BCC) and squamous cell 
carcinoma (SCC), referred to as NMSC, cause sig-
nificant morbidity and generate substantial cost to 
health care system. NMSC are 18-20 times more 
frequent than cutaneous MM (5). There is a great 
need for defining the epidemiological trend of 
these tumors in order to take appropriate preven-
tive actions. Precise population based estimates 
are crucial for the development of prevention strat-
egies and caregiving.
Our retrospective study established epide-
miological data on cutaneous cancers at Univer-
sity Department of Dermatology and Venereology, 
Zagreb University Hospital Center and School of 
Medicine, and compared them with recent litera-
ture data (2,5,11,17,25,33). Accurate epidemio-
logical data can be used to predict future cancer 
incidence by using trend modeling of the NMSC 
and MM rates observed. In recent literature, pre-
dictions are described by de Vries et al. (2005) for 
The Netherlands to up to 2015 (11).
We were also interested to see whether the 
epidemiology of cutaneous tumors in younger 
population in Croatia showed similar trends that 
were observed and described in the literature 
(23,27,28).
PATIENTS AND METHODS
Data for four consecutive years (January 2003 
– December 2006) were retrieved from our Labo-
ratory of Dermatological Histopathology database. 
The study was of a retrospective and partly hos-
pital-based design. We recorded all newly diag-
nosed invasive and in situ skin cancers by use 
of histopathology record forms containing the 
following data: patient name, clinical history and 
diagnosis, location, sex, birth date and histopatho-
logic description with definitive histopathologic di-
agnosis. Data were mainly collected on patients 
from Zagreb and also those from different parts of 
Croatia referred to our Department. Recurrences 
and diagnostic duplicities (cancer after biopsy and 
then surgically excised) were excluded. On statis-
tical analysis, we used STATISTICA, Version 7.1. 
(StatSoft, Inc.) software.
RESULTS
From all histopathologically examined biopsies 
only reports related to skin tumors were selected. 
Overall, there were 2911 epidermal skin tumors 
out of 16938 biopsies, including MM and NMSC 
Table 1. Results of histopathology verified skin tumors in female and male patients during period 2003-2006
YEAR MALE SEX FEMALE SEX
NUMBER OF SKIN TUMORS 
RECORDED DURING THE 
SPECIFIC YEAR/ NUMBER OF 
PATIENTS WITH SKIN TUMORS
NUMBER OF ALL 
HISTOPATHOLOGY 
MATERIALS EXAMINED 





















TOTAL 1431 1480 2911 cases2402 patients 16938
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(Table 1). The percentage of skin tumors ranged 
between 16.11% and 18.44%, depending on the 
year. During the period of observation, we record-
ed patients with multiple tumor lesions. Relation-
ship between the number of patients and number 
of skin tumor cases is shown in Table 1.
Sex
According to sex distribution of patients with 
skin tumors during the study period, a slight male 
predominance was found in 2003 and 2005, 
whereas female predominance was observed in 
2004 and 2006. Total number of tumors in males 
and females, and percentage of tumors recorded 
during the specific year are shown in Table 1.
Analysis of sex distribution by use of x2-test 
showed statistically significant differences only 
in 2005 and 2006, however, it was not reliable. 
Therefore Fisher exact test was used, which yield-
ed significant sex difference (Pr<=P 0.0236) in fa-
vor of female in the 30-64 age group in 2006.
Age
Age groups of patients divided into decades (ten-
year range) are shown in Table 2. Data revealed 
the patients born from 1921 to 1930 and from 1931 
to 1940 to be most frequently affected, immediately 
followed by those born from 1941 to 1950. Skin tu-
mors were rarely found in younger patients, those 
born between 1961 and 1970 in particular, now rep-
resented by patients aged 30-39.
For simplicity of expression in further analy-
ses, age grouping according to WHO was used to 
divide study population into groups of young pa-
tients (less than 29 years), adults (from 30 to 64 
years) and old population (older than 65 years). 
During the observed period, the mean patient age 
was 69.48 years, standard deviation 12.227; and 
median of patient age 71 years. During the study 
period, there was no change in the mean age or 
age median (Table 3).
Histopathologic diagnosis
The number of cases of skin tumors according 
to histopathologic diagnosis is presented in Table 
4. BCC, SCC, MM and cutaneous lymphomas 
(CL) were closely analyzed. Other, less common 
skin tumors were also noted. BCC was found to be 
most common.
Localization
During data collected, 36 different localizations 
of skin tumors were considered (Table 5); 14 local-
izations were differentiated on the face due to sun 
exposure. The five most common localizations of 
skin tumors observed during the study period are 
shown in Table 6. Of these the nose was most 
frequently involved. In 2003, nose was the most 
frequent localization with 127 cases, followed by 
buccal region (cheeks) with 118 and frontal re-
gion with 115 cases. In 2004, nose was the most 
frequent localization with 136 cases, followed by 
frontal region with 133 cases. However, in 2005, 
the most frequent localization was the back with 
106 cases, followed by the nose with 97 cases. In 
2006, nose was the most frequent site of skin tu-
mors again with 101 cases, closely followed by the 
back with 99 cases. During the study period, the 
nose, frontal region, buccal region and the back 
were the most commonly affected areas. For con-
venience, total number of tumors and percentage 
of all skin tumors recorded during the specific year 
are presented in Table 6.
Table 2. Number of skin tumors according the age 
groups of patients during 2003-2006
Age group
2003  2004 2005 2006
1900-1910 6 2 7 4
1911-1920 54 57 33 36
1921-1930 280 231 208 194
1931-1940 222 273 198 238
1941-1950 123 124 93 129
1951-1960 35 47 59 57
1961-1970 20 17 30 21




unknown date of birth 9 16 22 20
total  number of skin 
tumors in specific year
765 775 663 708
Table 3. Median, mean patients’ age and standard deviation during the observed period
PHD Mean patients’ age Std. Deviation Median of age Minimum Maximum
Mycosis fungoides 58.78 14.811 62.00 23 79
Other types of cutaneous lymphomas 69.56 16.210 74.00 45 91
Melanoma 62.96 16.966 68.00 19 90
Planocellular carcinoma 72.72 11.124 74.00 28 103
Basocellular carcinoma 68.52 12.116 70.00 9 99
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Table 5. Number of all skin tumors according to 
their localizations
Localization 2003 2004 2005 2006
Frontal region 115 133 70 85
Buccal region (cheeks) 118 89 51 70
Nose 127 136 97 101
Upper palpebra  
(if specified so)
5 1 3
Lower palpebra  
(if specified so)
1 2 17 13
Medial eye corner 4 3 2
Lateral eye corner 1
Lower lip (if specified so) 12 14 12 15
Upper lip (if specified so) 7 13 2 4
Mental region 4 4 5 13
Nasolabial sulcus 5 7 9
Ears 18 29 26 23
Preauricular region 21 26 15 14
Retroauricular region 13 11 7 19
Scalp 21 13 15 18
Neck 26 21 24 33
Trunk 34 5 1 1
Back 85 79 106 99
Chest 17 29 39 41
Abdominal region 26 23 13 11
Mammilar region 2 7
Shoulder and brachial 
region
26 32 29 27
Antebrachial region 20 17 15 10
Dorsal and palmar hand 
side
14 7 4 7
Axillar region 4 1 2 1
Fingers 1 6 1
Femoral region 11 20 14 17
Crural region 16 33 27 32
Foot 9 5 8 7
Toe fingers 1
Gluteal region 2 5 4 1
Vulva 5
Penis 2
Inguinal region 4 2
Genital and perigenital 
region 
1
Unknown localization  
(not specified)
8 6 32 26
Basal cell carcinoma
During the study period, 2002 BCC cases were 
recorded, accounting for 68.77% of all skin tumors 
registered during this period (Fig. 1). The highest 
number of BCC were recorded in 2004 (n=535), 
whereas in 2005 it was the most commonly diag-
nosed skin cancer (Table 4).
The BCC vs. SCC ratio was 2.93 in 2003, 3.39 
in 2004 and 3.56 in 2005. In 2006, the number of 
SCC decreased, yielding a higher BCC vs. SCC 
ratio of 6.45. The mean BCC to SCC ratio through-
out the study period was 4.08. The relationship and 
Table 4. Type and number of skin tumors accord-
ing to histopathology diagnosis during observed 
period
PHD 2003 2004 2005 2006
CARCINOMA 
BASOCELLULARE
491 535 442 534
CARCINOMA 
PLANOCELLULARE




2 1 2 2
BOWEN DISEASE 40 41 43 42




KERATOACANTHOMA 13 15 7 8
MELANOACANTHOMA 1
MYCOSIS FUNGOIDES 10 2 7 7
LYMPHOMA CUTIS 7 1 1
ANGIOKERATOMA 3
CLEAR CELL ACANTHOMA 2 2
MORBUS PAGET 2 1 1 3
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percentage of the three most frequent skin can-
cers are shown in Figure 2 and according to age 
groups in Figure 3. However, during the study pe-
riod, no statistically significant change was noted 
either for BCC or SCC. BCC was found in younger 
patients, with the exception of 2004 (Figs. 4-7). 
BCC was most frequently diagnosed in elderly 
patients (age group over 65). The percentage of 
BCC increased with age. The mean age of BCC 
patients was 68.52, standard deviation 12.116 and 
median age 70 years (Table 3).
According to sex distribution, BCC was slightly 
more common in female (n=1029; 51.39%) than in 
male population (n=973; 48.60%. Analysis of sex 
differences in BCC localization showed nose to be 
more frequently affected in females (20.79% vs. 
16.03%), while ears, neck and chest were more 
frequently affected in males (3.59% vs.1.65%; 
5.14% vs.3.49%; 5.75% vs. 3.49%). No differenc-
es were observed in other localizations of BCC 
(Fig. 8).
Squamous cell carcinoma
Total number of SCC was 533. This type of 
skin cancer accounted for 18.31% of all skin tu-
mors during the 4-year study period (Fig. 1). SCC 
was found in the 30-64 and >65 age groups, with 
the exception of 2004 when one case of SCC was 
identified in the <29 age group. We found 78.91% 
of SCC patients to be older than 65 years (Figs. 
4-7). The mean age was 72.72 years, standard 
deviation 11.124 and median age 74 years (Table 
3). There was no statistically significant change in 
SCC during the study period.
Analysis of sex distribution revealed a slight 
male predominance (54.78%). Frontal region was 
the most common localization of SCC (18.76%), 
followed by buccal region (15.95%) and nose 
(15.19%). However, lower lip was also frequently 
involved (9%). According to our study results, low-
er lip was the most frequent localization of SCC.
Analysis of sex differences in SCC localization 
showed it to more frequently occur on lower lip in 
male than in female patients (10.27% vs.7.47%) 
(Fig. 9). In addition, it was more commonly found 
in male patients on ears, and in preauricular and 
retroauricular region (15.07% vs. 5.81%). Males 
had SCC on the neck, while in females it was ex-
tremely rarely found at this location (7.88% vs. 
Figure 2. Percentage of three most important skin 
















Figure 3. Percentage of skin tumors during 
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0.41%). In female patients, SCC was more com-
mon on the cheeks (21.99% vs. 10.96%) and nose 
(19.09% vs. 11.99%). However, SCC on lower legs 
was almost exclusively found in female patients.
Melanoma
MM was a rare finding in our material (n=46). 
MM was found and verified in 1.58% of all cases 
of skin tumors and 0.27% of all biopsies exam-
ined (Fig. 1). The number of MM was observed to 
rise from 2003 to 2005, when the highest number 
of MM recorded (Table 4). In 2005, 18 MM cases 
were histopathologically verified. However, there 
was no statistically significant change in MM group 
during the study period.
MM was found in all three age groups (Figs. 4-
7). MM was most frequently found in elderly pop-
ulation (54.35%), closely followed by the group 
of adults (41.30%), while only one case was re-
corded in younger population in 2004. The mean 
age was 62.96 years, standard deviation 16.966, 
median age 68 years (Table 3). According to sex 
distribution, a slight male predominance was ob-
served, with 52.17% of all MM cases recorded in 
male patients.
Analysis of MM according to localization 
showed the majority of cases to occur on the back 
(23.91%), followed by the face (19.56%) and lower 
legs (13.04%) (Fig. 10). 
Table 6. Five most frequent localizations of skin tumors during years 2003 to 2006




























































Figure 4. Distribution and number of skin tumors 





















Figure 5. Distribution and number of skin tumors 



















Figure 6. Distribution and number of skin tumors 
according to age groups in year 2005
MM localization showed sex differences. In fe-
male patients MM was found on the face (28.57%), 
back (23.81%) and femoral region (19.05%). Other 
localizations included abdomen, antebrachial re-
gion and lower leg (Fig. 10). In men, the most fre-
quent localization of MM was on the back (24%), 
whereas all other localizations were less common 
and included the face, neck, chest, abdomen, bra-
chial and antebrachial region, femoral region, and 
lower leg.
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In 2003, two metastatic MM cases were verified 
on the skin. These metastatic MMs were excluded 
from other types of metastatic tumors that were 
found in the skin. Primary sites of these metastatic 
MMs in the skin were unknown to us. 
Cutaneous lymphoma
Cutaneous lymphoma (CL) was also rarely 
found, accounting for 1.2% of all cases of skin tu-
mors and 0.2% of all skin biopsies examined (Fig. 
1). During the 4 study years, 35 CL cases were 
recorded (Table 4). The highest number of CL 
(n=17) was recorded in 2003. In 2004, only 2 CL 
cases were recorded, then 8 cases in 2005 and 8 
cases in 2006. 
MF patients was 58.78, standard deviation 14.811 
and median of age 62 years (Table 3). The mean 
age of patients with other types of CL was 69.56, 
standard deviation 16.210 and median of age 74 
years.
DISCUSSION AND CONCLUSIONS
BCC and SCC are usually classified as NMSC. 
These skin tumors are probably the most common 
tumors in human population, however, as they 
have very low mortality rate (15,21,22,32), these 
tumors have not been systematically collected 
and included in the National Cancer Registry (1-
9,13-15,17-19). The incidence of NMSC and MM 
is rising throughout the world. Evaluation of these 
trends in skin cancer will allow for better planning 
the prevention of skin cancer in the future. 
Recent literature data confirm rapid increase 
in the incidence of NMSC worldwide (2,3,5,9,34). 
Data are mainly available for the USA and Aus-
tralia, suggesting that the incidence of NMSC has 
been on an increase. According to Revenga Ar-
ranz et al., 43000 new BCC and 15000 new SCC 
cases will be diagnosed every year in Spain, pos-
ing tremendous costs for healthcare systems (25). 
Direct costs of health services treating NMSC 




















Figure 7. Distribution and number of skin tumors 
according to age groups in year 2006










Figure 8. Localizations of  basocellular carcinoma 
according to sex








Figure 9. Localizations of planocellular carcinoma 
according to sex
The most frequent and most commonly found 
CL was mycosis fungoides (MF). For simplicity of 
expression, we separated MF from other CL types 
(group named in charts as lymphoma group). Re-
sults are shown in Figure 11. Out of 35 CL cases, 
26 were MF (74.29%).
Analysis of CL patients according to age 
groups showed 100% of MF cases to be in the 
<29 age group. In adult group, 80% were MF and 
20% other types of CL. The percentage of other 
CL was rising with age (Fig. 12). The mean age of 










Figure 10. Melanoma localizations according to 
sex. 
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treatment of breast cancer (12,15). However, now-
adays there is still little information from European 
countries (5-7,9,17,18,25).
There are no literature data on the epidemiol-
ogy of NMSC in Croatia, since oncotypes are have 
only been collected on hospitalized patients. The 
majority of these skin tumors are excised in toto 
at outpatient facilities. MM, however, is recorded 
more systematically in Croatia and there are some 
recently published literature data on the issue 
(10).
We were mainly interested in four types of skin 
tumor, i.e. BCC, SCC, MM and CL. Other, less 
frequently found skin tumors were also noted. In-
vasive carcinomas and in situ carcinomas were 
included, whereas cutaneous metastatic tumors 
were excluded.
We recorded 2911 cases of skin tumors. BCC 
was the most common skin cancer and the most 
commonly found NMSC. The second most com-
mon skin cancer found in our material was SCC. 
BCC was found in 2002 (68.77%), SCC in 533 
(18.31%), MM in 46 (1.58%) and CL in 35 (1.2%) 
cases. The highest number of BCC (n=535) were 
recorded in 2005. In 2005, BCC was the most 
commonly found skin cancer with 69.03% (the 
mean percentage throughout the study period was 
68.77%). These results are similar to the results of 
an epidemiological study conducted in Schleswig-
Holstein region, Germany (5). 
During data collection, we observed multiple 
skin tumors in our patients, which is comparable 
to recent literature data (12). When analyzing sex 
distribution, no statistical sex difference was ob-
served, with the exception of adult group (age 30-
64) in 2006, which showed a statistically signifi-
cant difference in terms of female predominance.
Our results confirm that skin cancers are more 
frequent in elderly population (mean age 68.94, 
median 71.00, standard deviation 12.656). These 
results are comparable with the results of a hos-
pital-based study in northern Spain: mean age 
71.4 for BCC and 77.3 for SCC (25). The most 
frequently affected age groups were those born 
during the 1921-1930 and 1931-1940 periods.
MM was most commonly found in elderly pop-
ulation (>65) (54.35%) and adult population (age 
30-64). It was rarely found in the group of young 
patients (<29); one case of MM was recorded in 
this age group.
During data collection, we considered 36 dif-
ferent localizations of skin tumors. Face was the 
most common localization of skin tumors, espe-
cially those with etiopathogenesis related to sun 
exposure. So, 14 different localizations were dif-
ferentiated for tumors found on the face. Our 
data also confirmed NMSC and MM to occur in 
sun exposed areas. Slight sex differences were 
observed, which could probably be explained by 
different sun exposure behavior (sun bathing, 
use of sunscreens), clothing differences, and hair 
length differences (especially for ears). BCC was 
frequently found on the nose, back and forehead, 
similar to the study reported by Revenga et al. in 
2004 (25). Analysis of sex differences in BCC local-
ization indicated the nose to be frequently affected 
in females (20.79% vs. 16.03%), while ears, neck 
and chest were more frequently involved in males 
(3.59% vs.1.65%; 5.14% vs.3.49%; and 5.75% 
vs. 3.49%, respectively). Other BCC localizations 
yielded no sex differences. Lower lip appeared to 
be exclusively reserved for SCC. SCC localization 
showed greater sex differences than BCC. Similar 
patterns were also observed for MM. As compared 
with female patients, in male patients SCC was 
more frequently found on lower lip (10.27% vs. 
7.47%) and ears (15.07% vs. 5.81%). Males had 
SCC on the neck, while it was extremely rarely 
found at this location in female patients (7.88% 
vs. 0.41%). Female patients had SCC more of-
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Years
Mycosis fungoides
other types of cutaneous
lymphoma
Figure 11. Distribution of the patients by year 
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Mycosis fungoides
Other types of cutaneous
lymphomas
Figure 12. Distribution of the patients by age 
group within cutaneous “lymphoma” tumour type
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(19.09% vs. 11.99%). However, SCC on lower legs 
was almost regularly found in female patients.
MM localizations also showed sex differ-
ences. In female patients, MM was found on the 
face (28.57%), back (23.81%) and femoral region 
(19.05%). Other localizations included abdomen, 
antebrachial region, and lower leg. In men, the 
most frequent localization of MM was the back 
(24%), while all other localizations were less fre-
quent and included the face, neck, chest, abdo-
men, brachial and antebrachial region, femoral 
region, and lower leg.
BCC was slightly more frequently found in 
female population. In younger population, only 
BCC was found, with the exception of 2004. MM 
was found in 31.15% of the adult group (age 3-
64), while the majority were elderly patients (age 
>65) (68.43%). The BCC to SCC ratio was 2.93 in 
2003, 3.39 in 2004, 3.56 in 2005, and 6.45 in 2006 
due to a decreased number of SCC in this year. 
We could not find any obvious explanation for the 
change in the BCC to SCC ratio. According to lit-
erature data, BCC is four times more frequently 
reported than SCC (6). The mean BCC to SCC 
ratio during the study period was 4.08, which is 
consistent with literature data (25).
SCC was recorded in 533 cases. Our results 
showed 78.91% of SCC patients to be older than 
65, confirming the fact that SCC is mostly found 
in elderly population. SCC was slightly more 
commonly found in males (54.78%). The most 
common localization of SCC was frontal region 
(18.76%), followed by buccal region (15.95%) and 
nose (15.19%). According to our study, lower lip 
(9%) was an exclusive localization of SCC.
There were 46 (1.58%) MM cases. MM was 
generally found in the elderly age group and group 
of adults. In our material, a slight male predomi-
nance was observed (52.17%). 
During the 2003-2006 period, 35 (1.2%) CL 
cases were histopathologically verified. The most 
frequent and most commonly found CL was MF. 
Out of 35 CL cases, 26 (74.29%) were diagnosed 
as MF. In younger group of patients, only MF was 
diagnosed. In elderly patients, other types of CL 
are more likely to be found than MF.
Our retrospective epidemiological study re-
vealed no increase in the rate of NMSC and MM 
during the 2003-2006 period. There was no sig-
nificant sex difference either. Age median was 
71 years. The trend observed in young popula-
tion and recently published in the literature was 
also studied. We recorded skin tumors in younger 
individuals, which is consistent with literature data 
(19,27,28,34). As these tumors do occur but are 
rare in young population groups, definitive conclu-
sions on these groups cannot be made with cer-
tainty. In the majority of cases, these tumors are 
localized in sun exposed areas.
In our study, we faced the problem of incom-
plete patient data, e.g., mainly localization and 
personal data such as birth date or place of resi-
dence, or data on sun exposure. Since skin tumors 
pose great burden for healthcare system and their 
number is growing daily, we suggest tight collabo-
ration of the registering dermatovenereologic and 
histopathologic facilities and other pathologists 
with the National Cancer Registry. The more accu-
rate epidemiological data are collected, the more 
comprehensive is our knowledge about the epide-
miology of skin cancers.
Preventive measures are suggested at the na-
tional level, such as the German campaign known 
as Sonne(n) mit Verstand (1). Good preventive 
measures have already yielded satisfactory re-
sults, e.g., preventive program in Australia, pri-
marily for melanoma and also for nonmelanoma 
skin cancers (15). We point to the need of mul-
tidisciplinary approach, collaboration of all large 
national centers of dermatology and venereology, 
along with other specialties and disciplines. The 
initiative of the Committee for Dermatology and 
Venereology of the Ministry of Health and Social 
Welfare of Republic of Croatia was launched in 
2008 on NMSC and MM prevention and prepara-
tion of the National Program for Prevention of Ma-
lignant Skin Cancers.
CONCLUSION
We have to develop strong interaction of care-
givers and patients in order to teach our patients 
on appropriate preventive measures. Preventive 
programs can get popularity through mass media 
(television, radio stations, newspapers and maga-
zines, internet-educational web sites with expert 
explanations and guidance). In view of the infor-
mation presented above, it is clear that the man-
agement of skin tumors, nonmelanoma and mela-
noma, will impose significant demands on health 
services in the years to come. It is up to dermato-
venereologists to take guidance in this difficult but 
not impossible task.
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